Cargando…
Synergistic action by multi-targeting compounds produces a potent compound combination for human NSCLC both in vitro and in vivo
By screening a collection of one hundred combinations of thiazolidinone compounds, we identified one combination (M4) that synergistically inhibited the growth of H460 and H460/TaxR cells and tumor growth in H460/TaxR xenograft mice. A whole genome microarray assay showed that genes involved in nega...
Autores principales: | Zhang, C, Zhai, S, Li, X, Zhang, Q, Wu, L, Liu, Y, Jiang, C, Zhou, H, Li, F, Zhang, S, Su, G, Zhang, B, Yan, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973217/ https://www.ncbi.nlm.nih.gov/pubmed/24651441 http://dx.doi.org/10.1038/cddis.2014.76 |
Ejemplares similares
-
Alternol/Alteronol: Potent Anti-cancer Compounds With Multiple Mechanistic Actions
por: Liu, Wang, et al.
Publicado: (2020) -
SRC and MEK Co-inhibition Synergistically Enhances the Anti-tumor Effect in Both Non-small-cell Lung Cancer (NSCLC) and Erlotinib-Resistant NSCLC
por: Yuan, Man, et al.
Publicado: (2019) -
The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs
por: Liu, Pei Y., et al.
Publicado: (2016) -
Compound Fracture of Both Forearms
por: Macdonald, T. R.
Publicado: (1885) -
Probing Synergistic Targets by Natural Compounds for Hepatocellular Carcinoma
por: Gao, Jian, et al.
Publicado: (2021)